Redundant functions of B-Myb and c-Myb in differentiating myeloid cells

Cell Growth and Differentiation

Volumn 8, Issue 12, 1997, Pages 1305-1316

  Golay, Josée ^a   Broccoli, Vania ^a   Borleri, Gian Maria ^c   Erba, Eugenio ^b   Faretta, Mario ^b   Basilico, Luca ^a   Ying, Guo Guang ^a   Piccinini, Gina ^a   Shapiro, Linda H ^d   Lovrić, Josip ^e   Nawrath, Michael ^e   Mölling, Karin ^e   Rambaldi, Alessandro ^c   Introna, Martino ^a,b  

^a Laboratory of Molecular Biology   (Italy)

^b Ospedali Riuniti ^*  (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; CD11B ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR; DNA; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; MICROSOMAL AMINOPEPTIDASE; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTO ONCOGENE;

ANTIGENS, DIFFERENTIATION; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOID; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 15144344274     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Hunter, T. Cooperation between oncogenes. Cell, 64: 249-270, 1991.
2. Warrel, R. P., Jr., de The, H., Wang, Z. Y., and Degos, L. Review: acute promyelocytic leukemia. N. Engl. J. Med., 329: 177-189, 1996.
3. Introna, M., Luchetti, M., Castellano, M., Arsura, M., and Golay, J. The myb oncogens family of transcription factors: potent regulators of hematopoietic cell proliferation and differentiation. Semin. Cancer Biol., 5: 113-124, 1994.
4. Golay, J., Basilico, L., Loffarelli, L., Songia, S., Broccoli, V., and Introna, M. Regulation of haematopoietic cell proliferation and differentiation by the myb oncogene family of transcription factors. Int. J. Clin. Lab. Res., 26: 24-32, 1996.
5. Graf, T. Myb: a transcriptional activator linking proliferation and differentiation in hematopoietic cells. Curr. Opin. Genet. Dev., 2: 249-255, 1992.
6. Mucenski, M. L., McLain, K., Kier, A. B., Swerdlow, S. H., Schreiner, C. M., Miller, T. A., Pietryga, D. W., Scott, W. J., and Potter, S. S. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell, 65: 677-689, 1991.
7. Gewirtz, A. M., and Calabretta, B. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science (Washington DC), 242: 1303-1306, 1988.
8. Selvakumaran, M., Liebermann, D. A., and Hoffman Liebermann, B. Deregulated c-myb disrupts interleukin-6-or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis. Mol. Cell Biol., 12: 2493-2500, 1992.
9. Smarda, J., and Lipsick, J. S. c-myb prevents TPA-induced differentiation and cell death in v-myb transformed monoblasts. Oncogene, 9: 237-245, 1994.
10. Cuddihy, A. E., Brents, L. A., Aziz, N., Bender, T. P., and Kuehl, W. M. Only the DNA binding and transactivation domains of c-myb are required to block terminal differentiation of murine erythroleukemia cells. Mol. Cell. Biol., 13: 3505-3513, 1993.
11. Rosson, D., and O'Brien, T. G, Constitutive c-myb expression in K562 cells inhibits induced erythroid differentiation but not tetradecanoyl phorbol acetate-induced megakaryotic differentiation. Mol. Cell. Biol., 15:772-779, 1995.
12. Lüscher, B., Christenson, E., Litchfield, D. W., Krebs, E. G., and Eisenman, R. N. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature (Lond.), 344: 517-522, 1990.
13. Aziz, N., Miglarese, M., Hendrickson, R. C., Shabanowitz, J., Sturgill, T. W., Hunt, D. F., and Bender, T. P. Modulation of c-myb transcription activation by a phosphorylation site near the negative regulatory domain. Proc. Natl. Acad. Sci. USA, 92: 6429-6433, 1995.
14. Ramsay, R. G., Morrice, N., Van Eeden, P., Kanagasundaran, V., Nomura, T., De Blaquiere, J., Ishii, S., and Wettenhall, R. Regulation of c-myb through protein phosphorylation and leucine zipper interactions. Oncogene, 11: 2113-2120, 1995.
15. Vorbrueggen, G., Lovric', J., and Moelling, K. Functional analysis of phosphorylation at serine 532 of human c-myb by MAP kinase. Biol. Chem., 377: 721-730, 1996.
16. Oelgeschläger, M., Krieg, J., Lüscher-Firzlaff, J. M., and Lüscher, B. Casein kinase II phosphorylation site mutations in c-myb affects DNA binding and transcriptional cooperativity with NF-M. Mol. Cell. Biol., 15: 5966-5974, 1995.
17. Miglarese, M. R., Richardson, A. F., Aziz, N., and Bender, T. P. Differential regulation of c-myb-induced transcription activation by a phosphorylation site in the negative regulatory domain. J. Biol. Chem., 271: 22697-22705, 1996.
18. Dash, A. B., Orrico, F. C., and Ness, S. A. The EVES motif mediates both intermolecular and intramolecular regulation of c-myb. Genes Dev., 10: 1858-1869, 1996.
19. Nomura, T., Sakai, N., Sarai, A., Sudo, T., Kanei-Ishii, C., Ramsay, R., Favier, D., Gonda, T. J., and Ishii, S. Negative autoregulation of c-myb activity by homodimer formation through the leucine zipper. J. Biol. Chem., 268: 21914-21923, 1993.
20. Howe, K. M., and Watson, R. J. Nucleotide preferences in sequence-specific recognition of DNA by c-myb protein. Nucleic Acids Res., 19: 3913-3919, 1991.
21. Tashiro, S., Takemoto, Y., Handa, H., and Ishii, S. Cell type specific trans-activation by the B-myb gene product: requirement of the putative cofactor binding to the C-terminal conserved domain. Oncogene, 10: 1699-1707, 1995.
22. Watson, R. J., Robinson, C., and Lam, E. W. F. Transcription regulation by murine B-myb is distinct from that of c-myb. Nucleic Acids Res., 21: 267-272, 1993.
23. Golay, J., Capucci, A., Arsura, M., Castellano, M., Rizzo, V., and Introna, M. Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood, 77: 149-158, 1991.
24. Arsura, M., Luchetti, M. M., Erba, E., Golay, J., Rambaldi, A., and Introna, M. Dissociation between p93B-myb and p75c-myb expression during the proliferation and differentiation of human myeloid cell lines. Blood, 83: 1778-1790, 1994.
25. Reiss, K., Travail, S., Calabretta, B., and Baserga, R. Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. J. Cell. Physiol., 148: 338-343, 1991.
26. Golay, J., Cusmano, G., and Introna, M. Independent regulation of c-myc, B-myo, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. J. Immunol., 149: 300-308, 1992.
27. Arsura, M., Introna, M., Passerini, F., Mantovani, A., and Golay, J. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. Blood, 79: 2708-2716, 1992.
28. Sala, A., and Calabretta, B. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and Cyclin-D1 expression. Proc. Natl. Acad. Sci. USA, 89: 10415-10419, 1992.
29. Raschella, G., Negroni, A., Sala, A., Pucci, S., Romeo, A., and Calabretta, B. Requirement of B-myb function for survival and differentiative potential of human neuroblastoma cells. J. Biol. Chem., 270: 8540-8545, 1995.
30. Bies, J., and Wolff, L. Acceleration of apoptosis in transforming growth factor β1 -treated M1 cells ectopically expressing B-myb. Cancer Res., 55: 501-504, 1995.
31. Rambaldi, A., Bettoni, S., Tosi, S., Giudici, G., Schirò, R., Borleri, G. M., Abbate, M., Chiaffarino, F., Colotta, F., Barbui, T., and Blondi, A. Establishment and characterization of a new GM-CSF-dependent and IL-3-dependent human acute myeloid leukemia cell line (GF-D8). Blood, 81: 1376-1383, 1993.
32. Foos, G., Natour, S., and Klempnauer, K-H. TATA-box dependent trans-activation of the human HSP70 promoter by myb proteins. Oncogene, 8: 1775-1782, 1993.
33. Patel, G., Tantravahi, R., Oh, I-H., and Reddy, E. P. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells. Oncogene, 13: 1197-1208, 1996.
34. Lam, E. W. F., and Watson, R. J. An E2F-binding site mediates cell cycle regulated repression of mouse B-myb transcription. EMBO J., 12: 2705-2713, 1993.
35. Toth, C. R., Hostutler, R. F., Baldwin, A. S., and Bender, T. P. Members of the nuclear factor kappa B family transactivate the murine c-myb gene. J. Biol. Chem., 270: 7661-7671, 1995.
36. Lam, E. W., Robinson, C., and Watson, R. J. Characterization and cell cycle-regulated expression of mouse B-myb. Oncogene, 7: 1885-1890, 1992.
37. Marhamati, D., and Sonenshein, G. E. B-myb expression in vascular smooth muscle cells occurs in a cell cycle dependent fashion and downregulates promoter activity of type I collagen genes. J. Biol. Chem., 271: 3359-3365, 1996.
38. Kastan, M. B., Stone, K. D., and Civin, C. I. Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells. Blood, 74: 1517-1524, 1989.
39. Foos, G., Grimm, S., and Klempnauer, K. H. Functional antagonism between members of the myb family. B-myb inhibits v-myb-induced gene-activation. EMBO J., 11: 4619-4629, 1992.
40. Burgess, T. L., Fisher, E. F., Ross, S. L., Bready, J. V., Qian, Y. X., Bayewitch, L. A., Cohen, A. M., Herrera, C. J., Hu, S. S. F., Kamer, T. B., Lott, F. D., Martin, F. D., Pierce, G. F., Simonet, L., and Farrell, C. L. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA, 92: 4051-4055, 1995.
41. Mizuguchi, G., Nakagoshi, H., Nagase, T., Nomura, N., Date, T., Ueno, Y., and Ishii, S. DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB. J. Biol. Chem., 265: 9280-9284, 1990.
42. Nakagoshi, H., Kanei Ishii, C., Sawazaki, T., Mizuguchi, G., and Ishii, S. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene, 7: 1233-1240, 1992.
43. Yanasigawa, H., Nagasawa, T., Kuramochi, S., Abe, T., Ikawa, Y., and Todokoro, K. Constitutive expression of exogenous c-myb gene causes maturation block in monocyte-macrophage differentiation. Biochim. Biophys. Acta, 167: 380-384, 1991.
44. Patel, G., Kreider, B., Rovera, G., and Reddy, E. P. v-myb blocks granulocyte colony-stimulating factor-induced myeloid cell differentiation but not proliferation. Mol. Cell. Biol., 13: 2269-2276, 1993.
45. Bies, J., Hoffman, B., Amamullah, A., Giese, T., and Wolff, L. B-myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene, 12; 355-363, 1995.
46. Selvakumaran, M., Lin, H-K., Sjin, R. T. T., Reed, J. C., Liebermann, D. A., and Huffman, B. The novel primary response gene Myd118 and the protooncogenes myb, myc, and bc/-2 modulate transforming growth factor β1-induced apoptosis of myeloid leukemia cells. Mol. Cell. Biol., 14: 2352-2360, 1994.
47. Carlos, T. M., and Harlan, J. M. Leukocyte-endothelial adhesion molecules. Blood, 84: 2068-2101, 1994.
48. Shapiro, L. H. Myb and ets proteins cooperate to transactivate an early myeloid gene. J. Biol. Chem., 270: 8763-8771, 1995.
49. Rubio, M. A., Lopez-Rodriguez, C., Nueda, A., Aller, P., Armesilla, A. L., Vega, M. A., and Corbi, A. L. Granulocyte-macrophage colonystimulating factor, phorbol ester, and sodium butyrate induce the GD11c integrin gene promoter activity during myeloid cell differentiation. Blood, 86: 3715-3724, 1995.
50. Pahl, H. L., Rosmarin, A. G., and Tenen, D. G. Characterization of the myeloid-specific CD11b promoter. Blood, 79: 865-870, 1992.
51. Jiang, H., Lin, J., Su, Z-Z., Collart, F. R., Huberman, E., and Fisher, P. B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1 expression in the absence of p53. Oncogene, 9: 3397-3406, 1994.
52. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell, 79: 573-582, 1994.
53. Peter, M., and Herskowitz, I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell, 79: 181-184, 1994.
54. Lin, D., Fiscella, M., O'Connor, P. M., Jackman, J., Chen, M., Luo, L. L., Sala, A., Travail, S., Appella, S., and Mercer, W. E. Constitutive expression of B-myb bypass p53-induced Waf1/Cip1-mediated G1 arrest. Proc. Natl. Acad. Sci. USA, 91: 10079-10083, 1994.
55. Sala, A., Casella, I., Bellon, T., Calabretta, B., Watson, R. J., and Peschle, C. B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. J. Biol. Chem., 271: 9363-9367, 1996.
56. Sala, A., Bellon, T., Melotti, P., Peschle, C., and Calabretta, B. Inhibition of erythromyeloid differentiation by constitutive expression of a DNA-binding deficient c-myb mutant: implication for c-myb function. Blood, 86: 3404-3412, 1995.
57. Lüscher, B., and Eisenman, R. N. Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J. Cell. Biol., 118: 775-784, 1992.
58. Aziz, N., Wu, J., Dubendorff, J. W., Lipsick, J. S., Sturgill, T. W., and Bender, T. P. c-myb and v-myb are differentially phosphorylated by p42mapk in vitro. Oncogene, 8: 2259-2265, 1993.
59. Majello, B., Kenyon, L. C., and Dalla-Favera, R. Human c-myb protooncogene: nucleotide sequence of cDNA and organization of the genomic locus. Proc. Natl. Acad. Sci. USA, 83: 9636-9640, 1986.
60. Golay, J., Loffarelli, L., Luppi, M., Castellano, M., and Introna, M. The human A-myb protein is a strong activator of transcription. Oncogene, 9: 2469-2479, 1994.
61. Ying, G-G., Arsura, M., Introna, M., and Golay, J. The DNA binding domain of the A-myb transcription factor is responsible for its B cell specific activity and binds to a B cell 110 KD nuclear protein. J. Biol. Chem., 272: 24921-24926, 1997.
62. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods, 65: 55-62, 1996.
63. Erba, E., Sen, S., Lorico, A., and D'Incalci, M. Potentiation of etoposide cytotoxicity against a human ovarian cancer cell line by pretreatment with non-toxic concentrations of methotrexate or aphidicolin. Eur. J. Cancer, 28: 66-77, 1992.
64. Baisch, H., Goehde, W., and Linden, W. A. Analysis of PCP data to determine the fraction of cells in the various phases of the cell cycle. Radiat. Environ. Biophys., 12: 31-41, 1975.